GE HealthCare Technologies (GEHC) Share-based Compensation (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Share-based Compensation came in at $45.0 million in Q2 2026, up 60.71% YoY from $28.0 million in Q2 2025, and up 28.57% on a QoQ basis from $35.0 million in Q1 2026.
GE HealthCare Technologies (GEHC) Share-based Compensation (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Share-based Compensation data on file, last reported at $45.0 million in Q2 2026.
- Quarterly Share-based Compensation rose 60.71% year-over-year to $45.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $154.0 million (up 38.74% YoY) and the FY2025 annual result came in at $130.0 million, up 4.0% from the prior year.
- Share-based Compensation improved to $45.0 million in Q2 2026, from $35.0 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $45.0 million in Q2 2026 to a low of $9.0 million in Q4 2022.
- A 5-year average of $28.7 million and a median of $28.5 million in 2023 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2023 — Share-based Compensation surged 266.67% — and 2024, when it slipped 24.14%.
- Tracing GEHC's Share-based Compensation over 5 years: stood at $9.0 million in 2022, then surged by 266.67% to $33.0 million in 2023, then changed by 0.0% to $33.0 million in 2024, then increased by 9.09% to $36.0 million in 2025, then climbed by 25.0% to $45.0 million in 2026.
- The last three Share-based Compensation figures came in at $45.0 million (Q2 2026), $35.0 million (Q1 2026), and $36.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.77 Bn | 194.17 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 126.93 Bn | 123.46 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.80 Bn | 109.58 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.34 Bn | 32.40 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.79 Bn | 31.69 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Zimmer Biomet Holdings | 19.18 Bn | 18.77 Bn | 1.54 Bn | 23.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.00 Mn |
| Jun 30, 2026 | 45.00 Mn |
| Mar 31, 2026 | 35.00 Mn |
| Mar 31, 2026 | 35.00 Mn |
| Dec 31, 2025 | 36.00 Mn |
| Dec 31, 2025 | 36.00 Mn |
| Sep 30, 2025 | 38.00 Mn |
| Sep 30, 2025 | 38.00 Mn |
| Jun 30, 2025 | 28.00 Mn |
| Jun 30, 2025 | 28.00 Mn |
| Mar 31, 2025 | 28.00 Mn |
| Mar 31, 2025 | 28.00 Mn |
| Dec 31, 2024 | 33.00 Mn |
| Dec 31, 2024 | 33.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | 36.00 Mn |
| Jun 30, 2024 | 36.00 Mn |
| Mar 31, 2024 | 34.00 Mn |
| Mar 31, 2024 | 34.00 Mn |